日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Challenging Cases in Urothelial Cancer: Case 31: LG Ta Bladder Cancer

尿路上皮癌疑难病例:病例31:LG Ta膀胱癌

Soloway, Mark S; Abrahams, Neil A

Challenging Cases in Urothelial Cancer: Case 32

尿路上皮癌疑难病例:病例32

Soloway, Mark S; Abrahams, Neil A

Challenging Cases in Urothelial Cancer: Case 33

尿路上皮癌疑难病例:病例33

Soloway, Mark S; Abrahams, Neil A; Pinnar, Nat

Inflection points in urology as witnessed by Mark Soloway. Part 1: bladder cancer

马克·索洛韦见证的泌尿外科转折点。第一部分:膀胱癌

Soloway, Mark S

Inflection points in urology as witnessed by Mark Soloway Part 2: Prostate and kidney cancers

马克·索洛韦见证的泌尿外科转折点(第二部分):前列腺癌和肾癌

Soloway, Mark S

Challenging Cases in Urothelial Cancer: Case 30: Rare Complication of BCG

尿路上皮癌疑难病例:病例30:卡介苗的罕见并发症

Soloway, Mark S

Challenging Cases in Urothelial Cancer: Case 28: Lynch Syndrome

尿路上皮癌疑难病例:病例28:林奇综合征

Soloway, Mark S

Targeting hyaluronic acid synthase-3 (HAS3) for the treatment of advanced renal cell carcinoma

靶向透明质酸合成酶-3 (HAS3) 治疗晚期肾细胞癌

Wang, Jiaojiao; Jordan, Andre R; Zhu, Huabin; Hasanali, Sarrah L; Thomas, Eric; Lokeshwar, Soum D; Morera, Daley S; Alexander, Sung; McDaniels, Joseph; Sharma, Anuj; Aguilar, Karina; Sarcan, Semih; Zhu, Tianyi; Soloway, Mark S; Terris, Martha K; Thangaraju, Muthusamy; Lopez, Luis E; Lokeshwar, Vinata B

Diffuse large B-cell lymphoma presenting as LUTS: Clinical practice points

弥漫性大B细胞淋巴瘤表现为下尿路症状:临床实践要点

Lokeshwar, Soum D; Rahman, Syed N; Syed, Jamil; Monaghan, Thomas F; Press, Benjamin; Soloway, Mark S

Clinical Parameters Outperform Molecular Subtypes for Predicting Outcome in Bladder Cancer: Results from Multiple Cohorts, Including TCGA

临床参数在预测膀胱癌预后方面优于分子亚型:来自包括TCGA在内的多个队列的研究结果。

Morera, Daley S; Hasanali, Sarrah L; Belew, Daniel; Ghosh, Santu; Klaassen, Zachary; Jordan, Andre R; Wang, Jiaojiao; Terris, Martha K; Bollag, Roni J; Merseburger, Axel S; Stenzl, Arnulf; Soloway, Mark S; Lokeshwar, Vinata B